The financials
Avantor, Inc. by the numbers
Avantor, Inc. (AVTR) reported revenue of $1.58B in Q1 2026 (quarter ended March 31, 2026), up 0.0% from the same quarter a year earlier. That came with a gross margin of 32% and net income of $43M (2.7% of revenue). For the full year FY2025, revenue was $6.55B (−3.4% year on year) and net income −$530M. Its largest segment in 2026-Q1 was VWR Distribution Services at $1.15B, 73% of the disclosed total, just ahead of Bioscience Medtech Products at 27%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $1.58B | $1.58B | 0.0% |
| Gross profit | $501M | $535M | −6.4% |
| Operating income | $100M | $147M | −32% |
| Net income | $43M | $65M | −33% |
| Diluted EPS | $0.06 | $0.09 | −33% |
| Operating | Revenue | Share |
|---|---|---|
| VWR Distribution Services | $1.15B | 73% |
| Bioscience Medtech Products | $431M | 27% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q1 2026Total $1.58B (-2.6%)
Bioscience Medtech Products grew +1.2% year on yearVWR Distribution Services -0.43% year on year
Segment Latestyear on year
- VWR Distribution Services$1.15B$1.15Byear on year -0.43%-0.43%
- Bioscience Medtech Products$431.4M$431.4Myear on year +1.2%+1.2%
- Bioscience Production--year on year --
- Laboratory Solutions--year on year --
Medical Instruments & Supplies
Ranks #22 of 27 by Smart Score